-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ga08qcJGZFX+SuBeVPAWNtOSFU6tWcwL/wraoRjUDj0SfMGdmizm/GEGKvvNU+MC wB2KihXxbhkXGxYgiR/P7w== 0001005477-02-002005.txt : 20020508 0001005477-02-002005.hdr.sgml : 20020508 ACCESSION NUMBER: 0001005477-02-002005 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-67506 FILM NUMBER: 02637671 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE RD CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 7329804500 MAIL ADDRESS: STREET 1: C/O DORSEY & WHITNEY LLP STREET 2: 250 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10177 424B3 1 d50574_424b3.txt PROSPECTUS SUPPLEMENT 7 PROSPECTUS SUPPLEMENT NO. 7 Filed pursuant to Rule 424(b)(3) (To prospectus dated October 24, 2001) Registration No. 333-67506 $400,000,000 Enzon, Inc. 4 1/2% Convertible Subordinated Notes Due 2008 ---------- This Prospectus Supplement No. 7 supplements and amends the Prospectus dated October 24, 2001 relating to the 4 1/2% Convertible Subordinated Notes due 2008 of Enzon, Inc. and the shares of common stock into which the notes are convertible, at various times at market prices prevailing at the time of sale or at privately negotiated prices. The table on pages 38 through 40 of the prospectus, which sets forth information with respect to the selling holders and the respective amounts of notes beneficially owned by each selling holder, is hereby amended as follows: The deletion from Supplement No. 1 to the prospectus of: Morgan Stanley & Co............................... $15,000,000 and the substitution of the following: Morgan Stanley & Co............................... $19,135,000 The Prospectus, together with Prospectus Supplement Nos. 1, 2, 3, 4, 5 and 6 and this Prospectus Supplement No. 7, constitutes the prospectus required to be delivered by Section 5(b) of the Securities Act of 1933, as amended, with respect to offers and sales of the notes and the common stock issuable upon conversion of the notes. All reference in the prospectus to "this prospectus" are hereby amended to read "this prospectus (as supplemented and amended)". Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. The date of this Prospectus Supplement is May 8, 2002. -----END PRIVACY-ENHANCED MESSAGE-----